Article Details

European Commission approves Roche's Xofluza for influenza treatment in children

Retrieved on: 2023-01-13 11:33:45

Tags for this article:

Click the tags to see associated articles and topics

European Commission approves Roche's Xofluza for influenza treatment in children. View article details on hiswai:

Excerpt

EC has granted approval for Roche's Xofluza (baloxavir marboxil) to treat and prevent influenza in children aged one year and above.

Article found on: www.pharmaceutical-technology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up